CLINICAL_TRIALS
trial_result
· 2010-04-19
Clinical Trial Update: Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 trial update evaluating pioglitazone added to existing therapy in adults with type 2 diabetes mellitus. Results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2010-04-19